DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy
Lysyl oxidase (LOX) controls matrix remodeling, a key process that underlies cardiovascular diseases and
heart failure; however, a lack of suitable animal models has limited our knowledge with regard to the contribution of
LOX to cardiac dysfunction. Here, we assessed the impact of LOX overexpression on ventricular function and cardiac
hypertrophy in a transgenic LOX (TgLOX) mouse model with a strong cardiac expression of human LOX. TgLOX mice
exhibited high expression of the transgene in cardiomyocytes and cardiofibroblasts, which are associated with enhanced
LOX activity and H2O2 production and with cardiofibroblast reprogramming. LOX overexpression promoted an ageassociated concentric remodeling of the left ventricle and impaired diastolic function. Furthermore, LOX transgenesis
aggravated angiotensin II (Ang II)–induced cardiac hypertrophy and dysfunction, which triggered a greater fibrotic
response that was characterized by stronger collagen deposition and cross-linking and high expression of fibrotic
markers. In addition, LOX transgenesis increased the Ang II–induced myocardial inflammatory infiltrate, exacerbated
expression of proinflammatory markers, and decreased that of cardioprotective factors. Mechanistically, LOX overexpression enhanced oxidative stress and potentiated the Ang II–mediated cardiac activation of p38 MAPK while
reducing AMPK activation. Our findings suggest that LOX induces an age-dependent disturbance of diastolic function
and aggravates Ang II–induced hypertrophy, which provides novel insights into the role of LOX in cardiac
performance, This work was cofunded by the Spanish Ministerio de
Econom´ıa y Competitividad (MINECO)–Instituto de Salud
Carlos III (ISCIII) (Grants PI15/01016, SAF2015-64767-R,
RD12/0042/0021 and RD12/0042/0053), Fundacio La ´
Marato de TV3 (20152330 and 20153610), and the Fondo ´
Europeo de Desarrollo Regional, a way to build Europe. Centros de Investigacion Biom ´ edica en Red de Enfermedades ´
Cardiovasculares is an initiative of ISCIII. M.G. was supported
by the Miguel Servet Program (ISCIII; CP15/00126)., Peer reviewed